It was amazing to have the opportunity to talk NGS with Matt Sause, the CEO of Roche Diagnostics, the world's largest clinical diagnostics provider with $17B in sales. Matt's businesses range across the full spectrum of DX products and services from diabetes CGM to Foundation Medicine oncology testing.

It was also great to find Josh Lauer on the call! Josh heads up the $4B (ie about the same size as Illumina) Molecular Diagnostics division, home to Roche's new SBX NGS technology. Josh came to Roche from Ultima Genomics, so he's very plugged in to the NGS ecosystem.